Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
23 04 2021
Historique:
received: 18 04 2020
revised: 11 06 2020
accepted: 09 07 2020
pubmed: 11 10 2020
medline: 4 1 2022
entrez: 10 10 2020
Statut: ppublish

Résumé

Prior studies have focused on the role of the kidney and vasculature in salt-induced modulation of blood pressure; however, recent data indicate that sodium accumulates in tissues and can activate immune cells. We sought to examine mechanisms by which salt causes activation of human monocytes both in vivo and in vitro. To study the effect of salt in human monocytes, monocytes were isolated from volunteers to perform several in vitro experiments. Exposure of human monocytes to elevated Na+ex vivo caused a co-ordinated response involving isolevuglandin (IsoLG)-adduct formation, acquisition of a dendritic cell (DC)-like morphology, expression of activation markers CD83 and CD16, and increased production of pro-inflammatory cytokines tumour necrosis factor-α, interleukin (IL)-6, and IL-1β. High salt also caused a marked change in monocyte gene expression as detected by RNA sequencing and enhanced monocyte migration to the chemokine CC motif chemokine ligand 5. NADPH-oxidase inhibition attenuated monocyte activation and IsoLG-adduct formation. The increase in IsoLG-adducts correlated with risk factors including body mass index, pulse pressure. Monocytes exposed to high salt stimulated IL-17A production from autologous CD4+ and CD8+ T cells. In addition, to evaluate the effect of salt in vivo, monocytes and T cells isolated from humans were adoptively transferred to immunodeficient NSG mice. Salt feeding of humanized mice caused monocyte-dependent activation of human T cells reflected by proliferation and accumulation of T cells in the bone marrow. Moreover, we performed a cross-sectional study in 70 prehypertensive subjects. Blood was collected for flow cytometric analysis and 23Na magnetic resonance imaging was performed for tissue sodium measurements. Monocytes from humans with high skin Na+ exhibited increased IsoLG-adduct accumulation and CD83 expression. Human monocytes exhibit co-ordinated increases in parameters of activation, conversion to a DC-like phenotype and ability to activate T cells upon both in vitro and in vivo sodium exposure. The ability of monocytes to be activated by sodium is related to in vivo cardiovascular disease risk factors. We therefore propose that in addition to the kidney and vasculature, immune cells like monocytes convey salt-induced cardiovascular risk in humans.

Identifiants

pubmed: 33038226
pii: 5872525
doi: 10.1093/cvr/cvaa207
pmc: PMC8064439
doi:

Substances chimiques

Antigens, CD 0
Cytokines 0
FCGR3B protein, human 0
GPI-Linked Proteins 0
Immunoglobulins 0
Inflammation Mediators 0
Lipids 0
Membrane Glycoproteins 0
Receptors, IgG 0
Sodium Chloride, Dietary 0
isolevuglandin 0
Sodium Chloride 451W47IQ8X
NADPH Oxidases EC 1.6.3.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1358-1371

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL130497
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL129941
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL140016
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01 HL121045
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Nat Rev Immunol. 2019 Apr;19(4):243-254
pubmed: 30644452
Exp Neurol. 2016 May;279:212-222
pubmed: 26976739
Circulation. 2011 Sep 20;124(12):1370-81
pubmed: 21875910
Hypertension. 2012 Jan;59(1):167-72
pubmed: 22146510
Hypertension. 1986 Jun;8(6 Pt 2):II127-34
pubmed: 3522418
Lancet. 2005 Jan 15-21;365(9455):217-23
pubmed: 15652604
Cell Rep. 2017 Oct 24;21(4):1009-1020
pubmed: 29069584
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):776-82
pubmed: 12637340
Immunity. 2013 Sep 19;39(3):599-610
pubmed: 24012416
Hypertension. 1991 Nov;18(5 Suppl):III49-53
pubmed: 1937686
Nat Med. 2009 May;15(5):545-52
pubmed: 19412173
Am J Physiol Regul Integr Comp Physiol. 2017 Dec 1;313(6):R706-R710
pubmed: 28931546
Nat Immunol. 2008 Jun;9(6):676-83
pubmed: 18469816
Acta Pathol Microbiol Scand A. 1972;80(2):253-6
pubmed: 5028054
Sci Rep. 2017 Jul 18;7(1):5655
pubmed: 28720883
Curr Hypertens Rep. 2013 Dec;15(6):538-46
pubmed: 24052211
Hypertension. 2015 Mar;65(3):569-76
pubmed: 25601932
Cell Res. 2015 Aug;25(8):893-910
pubmed: 26206316
PLoS One. 2012;7(7):e34050
pubmed: 22807997
Blood. 2000 Jun 1;95(11):3489-97
pubmed: 10828034
Science. 2017 Apr 21;356(6335):
pubmed: 28428369
Circ Res. 2016 Apr 15;118(8):1233-43
pubmed: 26988069
NMR Biomed. 2015 Jan;28(1):54-62
pubmed: 25328128
PLoS One. 2015 Oct 26;10(10):e0141336
pubmed: 26501774
Hypertension. 2001 Feb;37(2 Pt 2):429-32
pubmed: 11230313
Cell. 2017 Aug 24;170(5):860-874.e19
pubmed: 28803730
J Clin Invest. 2014 Oct;124(10):4642-56
pubmed: 25244096
Immunity. 2017 Dec 19;47(6):1037-1050.e6
pubmed: 29221729
J Cell Physiol. 2015 Aug;230(8):1740-9
pubmed: 25215878
Hypertension. 2017 Oct;70(4):660-667
pubmed: 28784646
N Engl J Med. 2013 Aug 1;369(5):448-57
pubmed: 23902484
Trends Immunol. 2011 Oct;32(10):470-7
pubmed: 21664185
Nat Protoc. 2007;2(9):2079-91
pubmed: 17853863
Blood. 1989 Nov 15;74(7):2527-34
pubmed: 2478233
Lancet. 1997 Dec 13;350(9093):1734-7
pubmed: 9413464
Kidney Int. 2018 May;93(5):1191-1197
pubmed: 29455909
J Immunol. 1988 Oct 1;141(7):2407-12
pubmed: 3139757
Circ Res. 2015 Jul 3;117(2):178-91
pubmed: 25963715
Br Heart J. 1954 Apr;16(2):133-41
pubmed: 13160264
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Hypertension. 2013 Mar;61(3):635-40
pubmed: 23339169
Genomics. 2014 May-Jun;103(5-6):323-8
pubmed: 24703969
Brief Funct Genomics. 2017 Jul 1;16(4):194-204
pubmed: 27687708
Nature. 2013 Apr 25;496(7446):518-22
pubmed: 23467095
Biomed Res Int. 2014;2014:248090
pubmed: 24977143
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3383-8
pubmed: 24550450
Hypertension. 2016 Jul;68(1):195-203
pubmed: 27160204
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004937
pubmed: 23633321

Auteurs

Natalia Ruggeri Barbaro (N)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.

Justin Van Beusecum (J)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.

Liang Xiao (L)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.

Luciana do Carmo (L)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.

Ashley Pitzer (A)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.

Roxana Loperena (R)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.

Jason D Foss (JD)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.

Fernando Elijovich (F)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.

Cheryl L Laffer (CL)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.

Kim R Montaniel (KR)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.

Cristi L Galindo (CL)

Division of Cardiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Wei Chen (W)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.

Mingfang Ao (M)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.

Raymond L Mernaugh (RL)

Department of Biochemistry, Vanderbilt University, Nashville, TN, USA.

Aseel Alsouqi (A)

Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Talat A Ikizler (TA)

Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Agnes B Fogo (AB)

Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Heitor Moreno (H)

Department of Intern Medicine, Faculty of Medical Sciences, Cardiovascular Pharmacology Laboratory, University of Campinas, Campinas, Brazil.

Shilin Zhao (S)

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

Sean S Davies (SS)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.

David G Harrison (DG)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.

Annet Kirabo (A)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Room 536 Robinson Research Building, Nashville, TN 37232-6602, USA.
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH